EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Andrological Outcomes in Boys Undergoing Testicular Tissue Extraction Prior to Gonadotoxic Treatment: Evolution During Peripuberty and Young Adulthood

Eulalie Martin, Hamza Benderradji iD, Laura Keller, Iva Gueorguieva, Christine Lefevre, Arthur Lauriot Dit Prevost iD, Berengère Ducrocq, François Marcelli, Anne-Sophie Defachelles, Pascal Pigny, Benedicte Bruno, Clara Leroy

Clinical Endocrinology · 2026

DOI: 10.1111/cen.70073 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Eulalie Martin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, DevGen, Reference Centre for Genital Development Abnormalities, University of Lille, CHU Lille, Lille, France. Hauptthemen laut MEDLINE: Testis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Advances in oncological and haematological treatments have markedly improved childhood survival, yet gonadotoxic therapies often compromise testicular function. Testicular tissue extraction (TTE) with cryopreservation is increasingly offered to prepubertal boys at high risk of infertility; however, data on long‐term endocrine and fertility outcomes remain limited. This study evaluated the long‐term endocrine and exocrine testicular function of males who underwent TTE prior to gonadotoxic therapy. Design and Patients This was a retrospective, observational, single‐centre study including 50 males treated between 2009 and 2022 at Lille University Hospital (median age at TTE: 5.6 years; median age at last follow‐up: 14.6 years). Underlying conditions comprised malignant haematological disorders (52%), non‐malignant diseases (34%), and solid tumours (14%); 80% underwent allogeneic haematopoietic stem cell transplantation.

Measurements

Serial clinical assessments and biochemical markers of Leydig and Sertoli cell function (LH, FSH, testosterone, inhibin B, AMH) were recorded from puberty onset to young adulthood. Data were stratified by treatment intensity, pubertal timing, and disease type. Post‐pubertal semen analysis was performed in consenting individuals.

Results

All participants experienced spontaneous pubertal onset. Sertoli cell dysfunction, evidenced by elevated FSH and persistently low inhibin B, was detectable early in puberty and persisted into adulthood. At Tanner stage 5, 18% had elevated LH, 75% elevated FSH, and 89% low inhibin B; comparable rates were observed in adulthood. Radiotherapy was associated with higher gonadotropin levels at equivalent chemotherapy doses, and Sertoli cell impairment was more pronounced in malignant disease and peri‐pubertal treatment. Among 12 semen analyses, spermatozoa were detected in 42%, all in non‐malignant cases without radiotherapy.

Conclusions

Males undergoing TTE prior to gonadotoxic therapy frequently develop persistent Sertoli cell dysfunction, with limited fertility potential in many cases. These findings underscore the importance of systematic, long‐term andrological surveillance and personalised fertility counselling in this high‐risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestisHumansMaleRetrospective StudiesAdolescentChildChild, PreschoolYoung AdultTestosteroneInhibinsSertoli CellsCryopreservationPubertyFollicle Stimulating HormoneLuteinizing HormoneAnti-Mullerian HormoneSemen AnalysisFertility PreservationLeydig CellsInfertility, Male

Stichwörter der Autor:innen

BoysLeydig cell functionSertoli cell functioncryopreservationfertility preservationgonadotoxicity

Substanzen

Testosteroneinhibin BInhibinsFollicle Stimulating HormoneLuteinizing HormoneAnti-Mullerian Hormone

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, DevGen, Reference Centre for Genital Development Abnormalities, University of Lille, CHU Lille, Lille, France.
  • Department of Endocrinology, Diabetology, and Metabolism, University of Lille, CHU Lille, Lille, France.
  • Department of Andrology, Urology and Renal Transplantation, University of Lille, CHU Lille, Lille, France.
  • University of Lille, CHU-Lille, Inserm U1172, Lille Neuroscience & Cognition, Lille, France.
  • Department of Reproductive Biology-Spermiology-CECOS, University of Lille, CHU Lille, Lille, France.
  • Department of Pediatric Surgery, University of Lille, CHU Lille, Lille, France.

ORCID-Profile: Hamza Benderradji, Arthur Lauriot Dit Prevost

Zitieren

APA

Martin, E., Benderradji, H., Keller, L., Gueorguieva, I., Lefevre, C., Prevost, A. L. D., Ducrocq, B., Marcelli, F., Defachelles, A. S., Pigny, P., Bruno, B., & Leroy, C. (2026). Andrological Outcomes in Boys Undergoing Testicular Tissue Extraction Prior to Gonadotoxic Treatment: Evolution During Peripuberty and Young Adulthood. Clinical Endocrinology. https://doi.org/10.1111/cen.70073

Vancouver

Martin E, Benderradji H, Keller L, Gueorguieva I, Lefevre C, Prevost ALD, et al. Andrological Outcomes in Boys Undergoing Testicular Tissue Extraction Prior to Gonadotoxic Treatment: Evolution During Peripuberty and Young Adulthood. Clinical Endocrinology. 2026. doi:10.1111/cen.70073

BibTeX
@article{Martin2026,
  author = {Martin, Eulalie and Benderradji, Hamza and Keller, Laura and Gueorguieva, Iva and Lefevre, Christine and Prevost, Arthur Lauriot Dit and Ducrocq, Berengère and Marcelli, François and Defachelles, Anne-Sophie and Pigny, Pascal and Bruno, Benedicte and Leroy, Clara},
  title = {Andrological Outcomes in Boys Undergoing Testicular Tissue Extraction Prior to Gonadotoxic Treatment: Evolution During Peripuberty and Young Adulthood},
  journal = {Clinical Endocrinology},
  year = {2026},
  doi = {10.1111/cen.70073}
}
Kostenlos starten →